MOHAMED BOUSSARSAR

Prof. Dr. MOHAMED BOUSSARSAR

Hôpital Farhat Hached, Sousse, Tunisia
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2002 in JAMA
Verified
Journal Article
Closed access
PDF file
BJBernard De Jonghe
Bernard De Jonghe
TSTarek Sharshar
Tarek Sharshar
JLJean-Pascal Lefaucheur
Jean-Pascal Lefaucheur
FAFrançois-Jérome Authier
François-Jérome Authier
IDIsabelle Durand-Zaleski
Isabelle Durand-Zaleski
FRFor The Groupe de Réflexion Et D'Etude Des Neuromyopathies En Réanimation
For The Groupe de Réflexion Et D'Etude Des Neuromyopathies En Réanimation
Research from JAMA — Paresis Acquired in the Intensive Care Unit — A Prospective Multicenter Study — ContextAlthough electrophysiologic and histologic neuromuscular abnormalities are common in intensive care unit (ICU) patients, the clinical incidence of ICU-acquired neuromuscular disorders in patients recovering from severe illness remains unknown.ObjectivesTo assess the clinical incidence, risk factors, and outcomes of ICU-acquired paresis (ICUAP) during recovery from critical illness in the ICU and to determine the electrophysiologic and histologic patterns in patients with ICUAP.DesignProspective cohort study conducted from March 1999 to June 2000.SettingThree medical and 2 surgical ICUs in 4 hospitals in France.ParticipantsAll consecutive ICU patients without preexisting neuromuscular disease who underwent mechanical ventilation for 7 or more days were screened daily for awakening. The first day a patient was considered awake was day 1. Patients with severe muscle weakness on day 7 were considered to have ICUAP.Main Outcome MeasuresIncidence and duration of ICUAP, risk factors for ICUAP, and comparative duration of mechanical ventilation between ICUAP and control patients.ResultsAmong the 95 patients who achieved satisfactory awakening, the incidence of ICUAP was 25.3% (95% confidence interval [CI], 16.9%-35.2%). All ICUAP patients had a sensorimotor axonopathy, and all patients who underwent a muscle biopsy had specific muscle involvement not related to nerve involvement. The median duration of ICUAP after day 1 was 21 days. Mean (SD) duration of mechanical ventilation after day 1 was significantly longer in patients with ICUAP compared with those without (18.2 [36.3] vs 7.6 [19.2] days; P = .03). Independent predictors of ICUAP were female sex (odds ratio [OR], 4.66; 95% CI, 1.19-18.30), the number of days with dysfunction of 2 or more organs (OR, 1.28; 95% CI, 1.11-1.49), duration of mechanical ventilation (OR, 1.10; 95% CI, 1.00-1.22), and administration of corticosteroids (OR, 14.90; 95% CI, 3.20-69.80) before day 1.ConclusionsIdentified using simple bedside clinical criteria, ICUAP was frequent during recovery from critical illness and was associated with a prolonged duration of mechanical ventilation. Our findings suggest an important role of corticosteroids in the development of ICUAP.

15 January 2002 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
MBMOHAMED BOUSSARSAR
MOHAMED BOUSSARSAR
GTGuillaume Thierry
Guillaume Thierry
SJSamir Jaber
Samir Jaber
FRFrançoise Roudot-Thoraval
Françoise Roudot-Thoraval
FLFrançois Lemaire
François Lemaire
LBLaurent Brochard
Laurent Brochard
Objective: High pressures or volumes may increase the risk of barotrauma in the acute respiratory distress syndrome (ARDS). Methods: The first part of the study analyzed data from a prospective trial of two ventilation strategies in 116 patients with ARDS retrospectively, and ventilatory pressures and volumes were compared in patients with or without pneumothorax. The second part consisted of a literature analysis of prospective trials (14 clinical studies, 2270 patients) describing incidence and risk factors for barotrauma in ARDS patients, and mean values of ventilatory parameters were plotted against incidence of barotrauma. Results: In our clinical trial comparing two tidal volumes, 15 patients (12.3%) developed pneumothorax. There was no significant difference in any pressure or volume between these patients and the rest of the population, including end-inspiratory plateau pressure (Pplat), driving pressure (Pplat-PEEP), respiratory rate and compliance. Multiple trauma was more frequent among patients with pneumothorax (27%) than in those without (7%). Duration of mechanical ventilation tended to be longer with pneumothorax. In the literature review, the incidence of barotrauma varied between 0% and 49%, and correlated strongly with Pplat, with a high incidence above 35 cmH2O, and with compliance, with a high incidence below 30 ml/cmH2O. Conclusion: Clinical studies maintaining Pplat lower than 35 cmH2O found no apparent relationship between ventilatory parameters and pneumothorax. Analysis of the literature suggests a correlation when patients receive mechanical ventilation with Pplat levels exceeding 35 cmH2O.

1 April 2000 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SJSamir Jaber
Samir Jaber
RFRedouane Fodil
Redouane Fodil
ACAnnalisa Carlucci
Annalisa Carlucci
MBMOHAMED BOUSSARSAR
MOHAMED BOUSSARSAR
JPJérôme Pigeot
Jérôme Pigeot
LBLaurent Brochard
Laurent Brochard
The use of helium–oxygen (HeO2) was tested in combination with noninvasive ventilation (NIV) in 10 patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). Effort to breathe as assessed by the respiratory muscle pressure-time index (PTI), work of breathing (WOB), and gas exchange were the main endpoints. Results of NIV-HeO2 were compared with those obtained with standard NIV (AirO2), at two levels of pressure-support ventilation (PSV), 9 ± 2 cm H2O and 18 ± 3 cm H2O. Significant reductions in PTI were observed between HeO2 and AirO2 at both the low PSV level (n = 9; 160 ± 58 versus 198 ± 78 cm H2O/s/ min; p < 0.05) and the high PSV level (n = 10; 100 ± 45 versus 150 ± 82 cm H2O/s/min; p < 0.01). WOB also differed significantly between HeO2 and AirO2 (7.8 ± 4.1 versus 10.9 ± 6.1 J/min at the low PSV level, p < 0.05; and 5.7 ± 3.3 versus 9.2 ± 5. J/min, p < 0.01 at the high PSV level). HeO2 reduced PaCO2 at both the low PSV level (61 ± 13 versus 64 ± 15 mm Hg; p < 0.05) and the high PSV level (56 ± 13 versus 58 ± 14 mm Hg; p < 0.05), without significantly changing breathing pattern or oxygenation. We conclude that use of HeO2 during NIV markedly enhances the ability of NIV to reduce patient effort and to improve gas exchange.

1 October 2005 in Critical Care Medicine
Verified
Journal Article
Closed access
SNSemir Nouira
Semir Nouira
SESouheil Elatrous
Souheil Elatrous
SDSaoussen Dimassi
Saoussen Dimassi
LBLamia Besbes
Lamia Besbes
RBRiadh Boukef
Riadh Boukef
FAFekri Abroug
Fekri Abroug
To investigate the effect of norepinephrine on static (right atrial pressure, pulmonary artery occlusion pressure ) and dynamic (pulse pressure variation and arterial systolic pressure variation) preload indicators in experimental hemorrhagic shock. Prospective controlled experimental study. Animal research laboratory. Six anesthetized and mechanically ventilated dogs. Dogs were instrumented for measurement of arterial blood pressure, pulmonary artery catheter derived variables including right atrial pressure, pulmonary artery occlusion pressure, and cardiac output. Simultaneously, pulse pressure variation and systolic pressure variation were calculated. Pulse pressure variation is the difference between the maximal and the minimal value of pulse pressure divided by the mean of the two values and is expressed as a percentage. Systolic pressure variation is the difference between the maximal and the minimal systolic pressure and is expressed as an absolute value. After baseline measurements, hemorrhagic shock was induced by a stepwise cumulative blood withdrawal of 35 mL·kg−1 of body weight. A second set of hemodynamic measurement was made 30 mins after bleeding. The third set was made 30 mins later under norepinephrine. Mean arterial pressure and cardiac output decreased after hemorrhage (p < .05), whereas right atrial pressure and pulmonary artery occlusion pressure remained unchanged. Baseline pulse pressure variation and systolic pressure variation increased significantly with hemorrhage, from 12% (9%) to 28% (11.5%) (p < .001) and from 12.5 (6.5) to 21 (8.2) mm Hg (p < .05), respectively. Norepinephrine induced a significant increase of cardiac output and a significant decrease of pulse pressure variation and systolic pressure variation but did not significantly change right atrial pressure or pulmonary artery occlusion pressure values. Stroke volume was correlated to pulse pressure variation and systolic pressure variation but was not correlated to right atrial pressure or pulmonary artery occlusion pressure. Our study confirms the superiority of dynamic variables (pulse pressure variation and systolic pressure variation) over static ones (right atrial pressure and pulmonary artery occlusion pressure) in assessing cardiac preload changes in hemorrhagic shock. However, norepinephrine could significantly reduce the value of these dynamic variables and mask a true intravascular volume deficit possibly by shifting blood from unstressed to stressed volume.

13 February 2003 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CBChristophe Baillard
Christophe Baillard
MBMOHAMED BOUSSARSAR
MOHAMED BOUSSARSAR
JFJean-Philippe Fosse
Jean-Philippe Fosse
EGEmmanuelle Girou
Emmanuelle Girou
PTPhilippe Le Toumelin
Philippe Le Toumelin
LBLaurent Brochard
Laurent Brochard

1 December 2013 in Respiratory Medicine
Verified
Journal Article
Closed access
Helmi Ben SaadHelmi Ben Saad
Helmi Ben Saad
MAMohamed Nour El Attar
Mohamed Nour El Attar
KMKhaoula Hadj Mabrouk
Khaoula Hadj Mabrouk
AAAhmed Ben Abdelaziz
Ahmed Ben Abdelaziz
AAAhmed Abdelghani
Ahmed Abdelghani
RSRouatbi Sonia
Rouatbi Sonia